Business Wire01.03.19
Miach Orthopaedics Inc., a privately held company dedicated to developing bio-engineered surgical implants for connective tissue repair, announced that medical device industry veteran Martha Shadan has been appointed president and chief executive officer. Miach’s first product under development is the Bridge-Enhanced ACL Repair (BEAR) technology, currently being studied in U.S. clinical trials. Shadan brings more than 30 years of medical device executive, marketing and commercialization expertise, and has been executive chairwoman of the Miach board since September 2018.
During most of 2018, Shadan served as global vice president of marketing at Smith & Nephew plc, a role she assumed after the company acquired Rotation Medical, where she was president and CEO. Shadan led the company through FDA approval and commercialization of the Rotation Medical Bioinductive Implant for rotator cuff tears (now known as REGENETEN), as well as the company’s acquisition by Smith & Nephew in December 2017.
“We are very glad to have Martha Shadan joining the Miach team,” said Martha Murray, M.D., founder and chief medical officer of Miach Orthopaedics. “Her experience in the medical device space with successful commercialization of medical devices brings in a very valuable skill set, and we are very much looking forward to working with her as the CEO.”
Shadan has successfully served in a number of senior leadership positions at Zimmer, Covidien, Bristol Myers Squibb Co., and Merck Millipore. She is actively involved with the Advanced Medical Technology Association (AdvaMed), serving on the Board of Directors since 2017; being a member of the Accel Board of Directors since 2015 and currently serving as its chairwoman; and being a founding member of the Leadership Circle for the Women's Executive Network (WEN). Shadan holds a master of business administration from Northeastern University, master of science in biology from Michigan State University, and bachelor of science in biology from the University of New Hampshire.
During most of 2018, Shadan served as global vice president of marketing at Smith & Nephew plc, a role she assumed after the company acquired Rotation Medical, where she was president and CEO. Shadan led the company through FDA approval and commercialization of the Rotation Medical Bioinductive Implant for rotator cuff tears (now known as REGENETEN), as well as the company’s acquisition by Smith & Nephew in December 2017.
“We are very glad to have Martha Shadan joining the Miach team,” said Martha Murray, M.D., founder and chief medical officer of Miach Orthopaedics. “Her experience in the medical device space with successful commercialization of medical devices brings in a very valuable skill set, and we are very much looking forward to working with her as the CEO.”
Shadan has successfully served in a number of senior leadership positions at Zimmer, Covidien, Bristol Myers Squibb Co., and Merck Millipore. She is actively involved with the Advanced Medical Technology Association (AdvaMed), serving on the Board of Directors since 2017; being a member of the Accel Board of Directors since 2015 and currently serving as its chairwoman; and being a founding member of the Leadership Circle for the Women's Executive Network (WEN). Shadan holds a master of business administration from Northeastern University, master of science in biology from Michigan State University, and bachelor of science in biology from the University of New Hampshire.